3:37 PM
 | 
Oct 18, 2018
 |  BC Extra  |  Politics & Policy

CMS’s Verma outlines new drug payment options

CMS Administrator Seema Verma Thursday outlined three types of payment arrangements the agency is considering for new, expensive medicines, such as gene therapies.

Speaking at the Brookings Institution, Verma said CMS may modify its regulations to allow for Medicare to pay for a “drug over time only if a...

Read the full 228 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >